| Year |
Citation |
Score |
| 2023 |
Karacosta LG, Pancirer D, Preiss JS, Benson JA, Trope W, Shrager JB, Sung AW, Neal JW, Bendall SC, Wakelee H, Plevritis SK. Phenotyping EMT and MET cellular states in lung cancer patient liquid biopsies at a personalized level using mass cytometry. Scientific Reports. 13: 21781. PMID 38065965 DOI: 10.1038/s41598-023-46458-5 |
0.59 |
|
| 2021 |
Bouchard G, Garcia-Marques FJ, Karacosta LG, Zhang W, Bermudez A, Riley NM, Varma S, Mehl LC, Benson JA, Shrager JB, Bertozzi CR, Pitteri SJ, Giaccia AJ, Plevritis SK. Multi-omics analysis of spatially distinct stromal cells reveals tumor-induced O-glycosylation of the CDK4-pRB axis in fibroblasts at the invasive tumor edge. Cancer Research. PMID 34853070 DOI: 10.1158/0008-5472.CAN-21-1705 |
0.662 |
|
| 2019 |
Karacosta LG, Anchang B, Ignatiadis N, Kimmey SC, Benson JA, Shrager JB, Tibshirani R, Bendall SC, Plevritis SK. Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution. Nature Communications. 10: 5587. PMID 31811131 DOI: 10.1038/S41467-019-13441-6 |
0.601 |
|
| 2019 |
Karacosta L, Anchang B, Ignatiadis N, Kimmey S, Benson J, Shrager J, Sung A, Neal J, Wakelee H, Tibshirani R, Bendall S, Plevritis S. OA08.03 A Single-Cell Resolution Map of EMT and Drug Resistance States for Evaluating NSCLC Clinical Specimens Journal of Thoracic Oncology. 14: S226-S227. DOI: 10.1016/J.Jtho.2019.08.449 |
0.558 |
|
| 2018 |
Anchang B, Davis KL, Fienberg HG, Williamson BD, Bendall SC, Karacosta LG, Tibshirani R, Nolan GP, Plevritis SK. DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity. Proceedings of the National Academy of Sciences of the United States of America. PMID 29654148 DOI: 10.1073/Pnas.1711365115 |
0.58 |
|
| 2018 |
Karacosta LG, Fisk JC, Jessee J, Tati S, Turner B, Ghazal D, Ludwig R, Johnson H, Adams J, Sajjad M, Koury S, Roy R, Olson JR, Rittenhouse-Olson K. Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging. Translational Oncology. 11: 450-466. PMID 29477636 DOI: 10.1016/J.Tranon.2018.01.008 |
0.362 |
|
| 2018 |
Karacosta LG, Anchang B, Kimmey S, Rijn Mvd, Shrager JB, Bendall SC, Plevritis SK. Abstract 4997: Identifying dynamic EMT states and constructing a proteomic EMT landscape of lung cancer using single cell multidimensional analysis Tumor Biology. DOI: 10.1158/1538-7445.Am2018-4997 |
0.591 |
|
| 2018 |
Anchang B, Davis K, Fienberg H, Bendall S, Karacosta L, Nolan G, Plevritis SK. Abstract 2275: Individualized drug combination based on single-cell drug perturbations Cancer Research. 78: 2275-2275. DOI: 10.1158/1538-7445.Am2018-2275 |
0.585 |
|
| 2017 |
Toumazis I, Kurt M, Toumazi A, Karacosta LG, Kwon C. Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer. Mdm Policy & Practice. 2: 2381468317729650. PMID 30288431 DOI: 10.1177/2381468317729650 |
0.636 |
|
| 2017 |
Tati S, Fisk JC, Abdullah J, Karacosta L, Chrisikos T, Philbin P, Morey S, Ghazal D, Zazala F, Jessee J, Quataert S, Koury S, Moreno D, Eng JY, Glinsky VV, et al. Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis. Neoplasia (New York, N.Y.). 19: 716-733. PMID 28830009 DOI: 10.1016/J.Neo.2017.07.001 |
0.342 |
|
| 2017 |
Gocher AM, Azabdaftari G, Euscher LM, Dai S, Karacosta LG, Franke TF, Edelman AM. Akt Activation by Ca2+/calmodulin-dependent protein Kinase Kinase 2 (CaMKK2) in Ovarian Cancer Cells. The Journal of Biological Chemistry. PMID 28634229 DOI: 10.1074/Jbc.M117.778464 |
0.671 |
|
| 2016 |
Karacosta L, Johnson H, Abdullah J, Chrisikos T, Ludwig R, Turner B, Tati S, Ghazal D, Sajjad M, Koury S, Morey S, Adams J, Rittenhouse-Olson K. Abstract 576: Immunohistochemistry and radioimaging with hJAA-11 antibody to the Thomsen-Friedenreich antigen: Potential theranostic application for breast cancer Cancer Research. 76: 576-576. DOI: 10.1158/1538-7445.Am2016-576 |
0.357 |
|
| 2015 |
Karacosta LG, Kuroski LA, Hofmann WA, Azabdaftari G, Mastri M, Gocher AM, Dai S, Hoste AJ, Edelman AM. Nucleoporin 62 and Ca(2+) /calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells. The Prostate. PMID 26552607 DOI: 10.1002/Pros.23121 |
0.685 |
|
| 2015 |
Gocher AM, Franke TF, Azabdaftari G, Karacosta LG, Edelman AM. Abstract B13: Regulation of Akt activity, cell proliferation, and viability in ovarian cancer cells by calcium/calmodulin-dependent protein kinase kinase 2 Molecular Cancer Therapeutics. 14. DOI: 10.1158/1538-8514.Pi3K14-B13 |
0.693 |
|
| 2012 |
Karacosta LG, Foster BA, Azabdaftari G, Feliciano DM, Edelman AM. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression. The Journal of Biological Chemistry. 287: 24832-43. PMID 22654108 DOI: 10.1074/Jbc.M112.370783 |
0.707 |
|
| 2012 |
Karacosta LG, Foster BA, Gissou A, Feliciano DM, Edelman AM. Abstract A10: CaMKK2 regulates cellular proliferation and androgen receptor activity during prostate cancer progression Cancer Research. 72: A10-A10. DOI: 10.1158/1538-7445.Prca2012-A10 |
0.695 |
|
| Show low-probability matches. |